DCF — ST. MICHAELS MEDICAL CENTER
Enterprise Value: $-415.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-415.2M
Enterprise Value
$-129.5M
PV of Cash Flows
$-285.7M
PV of Terminal Value
$-460.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $204.6M | $-26.9M | -13.0% | $-35.5M | $-32.3M |
| Year 2 | $210.7M | $-25.6M | -12.0% | $-34.5M | $-28.5M |
| Year 3 | $217.0M | $-24.2M | -11.0% | $-33.4M | $-25.1M |
| Year 4 | $223.5M | $-23.8M | -11.0% | $-33.2M | $-22.7M |
| Year 5 | $230.2M | $-23.9M | -10.0% | $-33.7M | $-20.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-415.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$198.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13642480466319826
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5